Related references
Note: Only part of the references are listed.Genetic suppression of atrial fibrillation using a dominant-negative ether-a-go-go-related gene mutant
Radim Soucek et al.
HEART RHYTHM (2012)
EphrinA1-EphA2 interaction-mediated apoptosis and FMS-like tyrosine kinase 3 receptor ligand-induced immunotherapy inhibit tumor growth in a breast cancer mouse model
Manish Tandon et al.
JOURNAL OF GENE MEDICINE (2012)
Special Issue: Guide to Receptors and Channels, 5th Edition Abstracts
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine model
Olympia Bikou et al.
CARDIOVASCULAR RESEARCH (2011)
被撤回的出版物: The Ephrin A1-EphA2 System Promotes Cardiac Stem Cell Migration After Infarction (Publication with Expression of Concern. See vol. 120, 2017) (Retracted article. See vol. 124, 2019)
Polina Goichberg et al.
CIRCULATION RESEARCH (2011)
Emerging strategies for EphA2 receptor targeting for cancer therapeutics
Manish Tandon et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Intramyocardial administration of chimeric ephrinA1-Fc promotes tissue salvage following myocardial infarction in mice
Jessica L. Dries et al.
JOURNAL OF PHYSIOLOGY-LONDON (2011)
The Aging Heart and Post-Infarction Left Ventricular Remodeling
Henry Shih et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
hERG K+ channel-associated cardiac effects of the antidepressant drug desipramine
Ingo Staudacher et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2011)
Lithocholic Acid Is an Eph-ephrin Ligand Interfering with Eph-kinase Activation
Carmine Giorgio et al.
PLOS ONE (2011)
Novel roles for hERG K+ channels in cell proliferation and apoptosis
J. Jehle et al.
CELL DEATH & DISEASE (2011)
Dual targeting of EphA2 and FAK in ovarian carcinoma
Mian M. K. Shahzad et al.
CANCER BIOLOGY & THERAPY (2009)
Apoptosis induction by doxazosin and other quinazoline α1-adrenoceptor antagonists: a new mechanism for cancer treatment?
Natasha Kyprianou et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2009)
Doxazosin induces apoptosis of cells expressing hERG K+ channels
Dierk Thomas et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Identification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase
Wei Bin Fang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling
Dana M. Brantley-Sieders et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
The EphA2 Receptor and EphrinA1 Ligand in Solid Tumors: Function and Therapeutic Targeting
Jill Wykosky et al.
MOLECULAR CANCER RESEARCH (2008)
RNA interference targeting EphA2 inhibits proliferation, induces apoptosis, and cooperates with cytotoxic drugs in human glioma cells
Zhangming Zhou et al.
SURGICAL NEUROLOGY (2008)
Silencing the receptor EphA2 suppresses the growth and haptotaxis of malignant mesothelioma cells
Najmunnisa Nasreen et al.
CANCER (2006)
Molecular mechanisms in heart failure - Focus on cardiac hypertrophy, inflammation, angiogenesis, and apoptosis
Denise Hilfiker-Klemer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Noonan syndrome and related disorders: dysregulated RAS-mitogen activated protein kinase signal transduction
Bruce D. Gelb et al.
HUMAN MOLECULAR GENETICS (2006)
Role of protein-tyrosine phosphatase SHP2 in focal adhesion kinase down-regulation during neutrophil cathepsin G-induced cardiomyocytes anoikis
Khadija Rafiq et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Doxazosin induces activation of GADD153 and cleavage of focal adhesion kinase in cardiomyocytes en route to apoptosis
Sonia Eiras et al.
CARDIOVASCULAR RESEARCH (2006)
Immunocompetent mouse model of breast cancer for preclinical testing of EphA2-targeted therapy
LW Noblitt et al.
CANCER GENE THERAPY (2005)
被撤回的出版物: EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma (Retracted article. See FEB, 2023)
MS Duxbury et al.
ONCOGENE (2004)
Ligation of EphA2 by Ephrin A1-Fc inhibits pancreatic adenocarcinoma cellular invasiveness
MS Duxbury et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1
LW Noblitt et al.
CANCER GENE THERAPY (2004)
Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways
S Cardin et al.
CARDIOVASCULAR RESEARCH (2003)
Doxazosin and terazosin suppress prostate growth by inducing apoptosis: Clinical significance
N Kyprianou
JOURNAL OF UROLOGY (2003)
Doxazosin induces apoptosis in cardiomyocytes cultured in vitro by a mechanism that is independent of α1-adrenergic blockade
JR González-Juanatey et al.
CIRCULATION (2003)
Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer
MS Kinch et al.
CLINICAL & EXPERIMENTAL METASTASIS (2003)
Receptor tyrosine kinase EphA2 is regulated by p53-family proteins and induces apoptosis
M Dohn et al.
ONCOGENE (2001)
The effect of lithocholic acid on proliferation and apoptosis during the early stages of colon carcinogenesis: differential effect on apoptosis in the presence of a colon carcinogen
V Kozoni et al.
CARCINOGENESIS (2000)
Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation
H Miao et al.
NATURE CELL BIOLOGY (2000)